CONSTRUCTION OF NEW SERIES OF SECOND ORDER ROTATABLE DESIGNS
Journal Title: IJAR-Indian Journal of Applied Research - Year 2019, Vol 9, Issue 11
Abstract
A new series of Second Order Rotatable Design is constructed using Balanced Ternary Design of Bhatra charyulu (2006). The existence of the method is proved and illustrated with a suitable example.
Authors and Affiliations
Kanna E. , Ameen Saheb Sk. , Bhatra Charyulu, N. Ch. *
Keywords
Related Articles
- EP ID EP664988
- DOI -
- Views 55
- Downloads 0
A Study on Prevalence of Subclinical Hypothyroidism in The First Degree Female Relatives of Hypothyroid Patients
Introduction:Subclinical hypothyroidism is mainly diagnosed by laboratory results as there are no presenting clinical signs and symptoms. There are only a few studies done on prevalence and patterns of age distributions...
Variant Course and Branching Pattern of Radial Artery Along with Variation in the Completion of Superficial Palmar Arch
In the hand variation in the completion of the superficial palmar arch is quiet common but the variation we found is quiet different from routine variations. Having knowledge regarding new variations is very important fo...
IMPLEMENTATION AND ADMINISTRATION OF SARVA SHIKSHA ABHIYAN AND GROWTH OF ELEMENTARY EDUCATION – A STUDY OF KEONJHAR DISTRICT IN ODISHA
The Sarva Shiksha Abhiyan was launched 2001 as flagship programme to give a boost to universal primary education. The main focus of the scheme was to increase enrolment, attendance and to reduce drop-outs among the prima...
DRUG EFFECT ON LEUKEMIA CELLS THROUGH SINGLE CELL ASSAY METHOD
Acute myeloid leukemia (AML) is a cancer of the myeloid line of blood cells that is characterized by accumulation of immature malignant cells in the bone marrow. Leukemia cells can hide in bone marrow niche or vascular n...
Aprepitant for treatment of refractory vomiting in a case of brain abscess
We report a case of brain abscess whose intractable nausea and vomiting improved significantly with aprepitant, a neurokinin (NK) receptor antagonist currently licensed only for prevention of chemotherapy-induced nause...